< Back to Find a Trial

A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia (FOXY)

ID

NCT03260920

Condition Studied

Frontotemporal Dementia

Phase

Phase II

Status

Closed

Intervention

Syntocinon

Principal Investigator

Adam Boxer, MD, PhD

[email protected]

415 - 476 - 0668

Please go to ClinicalTrials.gov for more information.